Insider · CIK 0001861790
Joseph Monahan
officer
Files at ACRS (Aclaris Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +50,000 | - | - | 281,995 | Mar 4, 2025 |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +10,925 | - | - | 292,920 | Mar 4, 2025 |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | FTax withholding Common Stock | -27,258 | $1.99 | $54k | 265,662 | Mar 4, 2025 |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -50,000 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Mar 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -10,925 | $0.00 | $0 | 10,925 | Mar 4, 2025 |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +7,500 | - | - | 228,562 | Feb 4, 2025 |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +14,750 | - | - | 243,312 | Feb 4, 2025 |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | FTax withholding Common Stock | -11,317 | $2.48 | $28k | 231,995 | Feb 4, 2025 |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,500 | $0.00 | $0 | 15,000 | Feb 4, 2025 |
| Feb 1, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,750 | $0.00 | $0 | 44,250 | Feb 4, 2025 |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +83,900 | $0.00 | $0 | 83,900 | Feb 4, 2025 |
| Feb 3, 2025 | ACRS Aclaris Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +293,500 | $0.00 | $0 | 293,500 | Feb 4, 2025 |
| Dec 31, 2024 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +73,750 | - | - | 245,533 | Jan 3, 2025 |
| Dec 31, 2024 | ACRS Aclaris Therapeutics, Inc. | FTax withholding Common Stock | -32,937 | - | - | 212,596 | Jan 3, 2025 |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Common Stock | +17,380 | - | - | 229,976 | Jan 3, 2025 |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | FTax withholding Common Stock | -8,914 | - | - | 221,062 | Jan 3, 2025 |
| Dec 31, 2024 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -73,750 | $0.00 | $0 | 73,750 | Jan 3, 2025 |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +52,667 | $0.00 | $0 | 52,667 | Jan 3, 2025 |
| Jan 2, 2025 | ACRS Aclaris Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -17,380 | $0.00 | $0 | 35,287 | Jan 3, 2025 |
| Dec 10, 2024 | ACRS Aclaris Therapeutics, Inc. | GGift Common Stock | -15,000 | $0.00 | $0 | 171,783 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.